Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

Clicks: 430
ID: 113941
2011
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Sensitive rapid anti-HCV assays are appropriate and feasible for high-prevalence, high-risk populations such as PWID, who can be reached through social service settings such as syringe exchange programs and methadone maintenance treatment programs.
Reference Key
bd2011clinicalperformance Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Smith BD;Teshale E;Jewett A;Weinbaum CM;Neaigus A;Hagan H;Jenness SM;Melville SK;Burt R;Thiede H;Al-Tayyib A;Pannala PR;Miles IW;Oster AM;Smith A;Finlayson T;Bowles KE;Dinenno EA;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2011
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.